Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Completed 2Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Myelodysplastic Syndromes 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Uveal Melanoma 1Recurrence 1Oligodendroglioma 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Lymphoma 1Lung Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Hematologic Diseases 1Graft vs Host Disease 1Gliosarcoma 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 14Temozolomide 10Specimen Handling 10X-Rays 8Radiotherapy 7Biopsy 7Phantoms, Imaging 6Nuclear Medicine Department, Hospital 6trametinib 4ulixertinib 3olaparib 3larotrectinib 3erdafitinib 3dabrafenib 3Radiotherapy, Intensity-Modulated 3Nivolumab 3tipifarnib 2selpercatinib 2pembrolizumab 2palbociclib 2niraparib 2ivosidenib 2ensartinib 2atezolizumab 2abemaciclib 2Surveys and Questionnaires 2Radiation 2Proton Therapy 2Lomustine 2Irinotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Glioma × Vorinostat × Clear all
NCT00268385 2026-05-07

Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas

National Cancer Institute (NCI)

Phase 1 Active not recruiting
83 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡